Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?
Abstract Background Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/...
Main Authors: | Istemi Serin, Nagehan Didem Sari, Murat Gunaltili, Ayse Karakilic, Begum Gulesir, Beyza Kal Kolik, Gulnihal Cevik, Hilal Sungurlu, Melike Keskin, Muhammed Baltik, Onurhan Cakmak, Tahir Alper Cinli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07303-8 |
Similar Items
-
Multisystem Inflammatory Syndrome in Adults Associated with Recent Infection with COVID-19
by: Ondrej Zahornacky, et al.
Published: (2023-03-01) -
Children’s Multisystem inflammatory syndrome with myopathy
by: Zina Maria Almeida de Azevedo, et al.
Published: (2021-03-01) -
Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review
by: Nicole Atchessi, et al.
Published: (2021-07-01) -
VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes
by: Darrell O. Ricke, et al.
Published: (2024-03-01) -
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
by: Şengül Çaǧlayan, et al.
Published: (2022-08-01)